Graham Capital Management, L.P. Rocket Pharmaceuticals, Inc. Transaction History

Graham Capital Management, L.P.

  • $5.08 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$12.37 - $18.41 $58,868 - $87,613
4,759 Added 7.51%
68,126 $1.09 Million
Q2 2022

Aug 15, 2022
BUY
$7.96 - $16.64 $43,955 - $91,886
5,522 Added 9.55%
63,367 $871,000
Q1 2022

May 16, 2022
BUY
$13.16 - $23.68 $761,240 - $1.37 Million
57,845 New
57,845 $917,000

Others Institutions Holding RCKT

# of Institutions
244
Shares Held
108M
Call Options Held
262K
Put Options Held
159K
View Full List

About ROCKET PHARMACEUTICALS, INC.

RCKT Quotes by TradingView
  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $638M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email